Skip to product information
1 of 1

Springer

Resistance To Immunotherapeutic Antibodies In Cancer: Strategies To Overcome Resistance (Resistance To Targeted Anti-Cancer Therapeutics, 2)

Resistance To Immunotherapeutic Antibodies In Cancer: Strategies To Overcome Resistance (Resistance To Targeted Anti-Cancer Therapeutics, 2)

ISBN-13: 9781489987327
Regular price $200.49
Regular price Sale price $200.49
Sale Sold out
The traditional approaches to treat various cancers include chemotherapy, radiation and/or hormonal therapy. While these therapies continue to be effective in large part, they are not selective and highly toxic. There have been encouraging results in alternative therapeutic approach called antibody-mediated anti-cancer therapy, which is less toxic, more selective, and can also reverse drug/radiation resistance.Monoclonal antibodies or mAbs can be used to destroy malignant tumor cells and prevent tumor growth by blocking specific cell receptors. mAbs can bind only to cancer cell-specific antigens and induce an immunological response against the target cancer cell. The book coversthe commonand unique features of mAbs agains various cancer, gives the latest developments onthe molecular, biochemical and genetic mechanisms of resistance by various mAbs, as well as discuss novel mAbs to overcome resistance." 9781489987327 1489987320 218 Medical NOT_MATURE http://books.google.com/books/content?id=o-cAswEACAAJ&printsec=frontcover&img=1&zoom=5&source=gbs_api en


  • Author: Benjamin Bonavida
  • Publisher: Springer
  • Publication Date: Aug 22, 2015
  • Number of Pages: 215 pages
  • Language: English
  • Binding: Paperback
  • ISBN-10: 1489987320
  • ISBN-13: 9781489987327
View full details